| Stage | CNP | % of rev | NEE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $8.1B | 100.00% | NEE ×3.69 |
| Gross profit | $1.3B | 57.33% | $4.3B | 52.53% | CNP +4.8pp |
| Operating income | $667M | 30.44% | $2.6B | 32.44% | NEE +2.0pp |
| Pre-tax income | $413M | 18.85% | $5.0B | 62.16% | NEE +43.3pp |
| Net income | $331M | 15.11% | $4.4B | 53.98% | NEE +38.9pp |
| Stage | CNP | NEE | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $8.1B100.00% | NEE ×3.69 |
| Gross profit | 57.33%$1.3B | 52.53%$4.3B | CNP +4.8pp |
| Operating income | 30.44%$667M | 32.44%$2.6B | NEE +2.0pp |
| Pre-tax income | 18.85%$413M | 62.16%$5.0B | NEE +43.3pp |
| Net income |
| 15.11%$331M |
| 53.98%$4.4B |
| NEE +38.9pp |
No shared counterparties.